65547-98-0Relevant articles and documents
ETHER COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS
-
Paragraph 0646, (2017/03/14)
Compounds, methods of use, and processes for making inhibitors of complement Factor D are provided comprising Formula I, I" and I? or a pharmaceutically acceptable salt or composition thereof. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade. The inhibitors of Factor D described herein reduces the excessive activation of complement.
Wavelength-selective photoactivatable protecting groups for thiols
Kotzur, Nico,Briand, Benoit,Beyermann, Michael,Hagen, Volker
supporting information; scheme or table, p. 16927 - 16931 (2010/04/04)
We developed and characterized efficient, remarkably water-soluble photolabile protecting groups for thiols based on 2-nitrobenzyl and (coumarin-4-yl)methyl chromophores, among them two new ones. The protecting groups allow, due to their different absorpt
OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION
-
Page/Page column 17-18, (2008/06/13)
This invention relates to potent potassium channel blocker compounds of Formula (I) or a formulation thereof for the treatment of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient. This invention also rela